Fairvalue-Calculator Fairvalue-Calculator
EN DE

Shin Nippon Biomedical Laboratories, Ltd (SBLOF) Fair Value & Analysis

Healthcare · US · Market cap $381M

Price$9.16
Fair Value$12.07
Upside+31.8%
Quality95/100
Evidence: High Range $9.05 – $15.09

Fair value as of: Jun 24, 2026

Analysis

Shin Nippon Biomedical Laboratories, Ltd (SBLOF) currently trades at $9.16, while our model-based Fair Value estimate is $12.07 — implying the stock looks roughly 31.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activities for proprietary products which utilize unique intranasal formulation delivery technology, discovery of future seeds, and business promotion activities; and development of artificial seed production for Japanese eels. In addition, it operates hotels accommodations facilities under the Villa Amafuru Oka and HOTEL Freesia names; and develops and operates geothermal and hot spring thermal power plants. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -96% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is Shin Nippon Biomedical Laboratories, Ltd (SBLOF) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $12.07 versus a price of $9.16 — about +32% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SBLOF?
Our 21-model fair value for Shin Nippon Biomedical Laboratories, Ltd is $12.07 (as of Jun 24, 2026), built from audited fundamentals. The current price is $9.16.
What is the quality score of SBLOF?
Shin Nippon Biomedical Laboratories, Ltd has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.